Research & Development
Research & Development

Research & Development Pipeline

Improving patients' lives through better healthcare begins with a commitment to innovation. Our research and development pipeline is where we put that commitment to work. Takeda Global Research & Development Center, Inc. dedicates its resources to the Takeda product pipeline in an effort to improve people’s lives. As a research-based pharmaceutical company efforts are currently focused on preclinical work and clinical development activities.

Compound Therapeutic Area Stage
alogliptin Diabetes mellitus NDA submitted
TAK-491 Hypertension Phase 3
Hematide Anemia associated with chronic renal failure (CRF) Phase 3
LuAA21004 Mood and anxiety disorders Phase 3
SYR-322-4833 Diabetes mellitus NDA submitted
MLNM002 Crohn’s and Ulcerative Colitis Phase 3

Our Products

Learn more about our products currently on the market.



Page Top